Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Airlie Small Companies Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD+44%
Annualized+0.158%
Positioning StanceCONSTRUCTIVE
Market CapSmallCap
Digest Analysis
Quick Take
"The fund underperformed its benchmark in Q3 2025 due to zero resource exposure and specific tech/healthcare drags, but the manager capitalized on reporting season volatility to build a major, high-conviction position in fast-food compounder Guzman y Gomez (GYG)."
Executive Summary
For the quarter ending September 30, 2025, the Airlie Small Companies Fund delivered a net return of 4.4%, underperforming its benchmark S&P/ASX Small Ordinaries Accumulation Index, which returned 15.3%. This relative underperformance of -10.9% was mainly due to the fund holding zero exposure to the resources sector, which experienced a 26% rally, while the fund's core focus area (Small Industrials) gained only 11%. Additionally, some stock-specific issues (e.g., Gentrack's customer loss and EBOS Group's guide down) dragged on returns, although positive performance from Nick Scali, Mader Group, and Joyce Corporation provided offsets. The manager used market volatility to materially increase their position in Guzman y Gomez (GYG), outlining a deep-dive thesis focused on GYG's premier unit economics, drive-thru expansion potential, and long-term runway for store rollouts in Australia.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
85%
CautiousHigh
High Conviction (85%)
High-conviction positioning: The fund underperformed its benchmark in Q3 2025 due to zero resource exposure and specific tech/healthcare drags, but the manager capitalized on reporting season volatility to bui...
Growth Outlook
70%
BearishBullish
Bullish (70%)
Market outlook remains above average conviction: The fund underperformed its benchmark in Q3 2025 due to zero resource exposure and specific tech/healthcare drags, but the manager capitalized on reporting season volatility to bui...
Risk Appetite
60%
DefensiveAggressive
Balanced (60%)
Risk appetite posture is above average conviction: The fund underperformed its benchmark in Q3 2025 due to zero resource exposure and specific tech/healthcare drags, but the manager capitalized on reporting season volatility to bui...
Capital Deployment
80%
De-riskingDeploying
Deploying (80%)
Manager actively deployed capital into high-conviction opportunities. The fund underperformed its benchmark in Q3 2025 due to zero resource exposure and specific tech/healthcare drags, but the manager capitalized on reporting season volatility to bui...
Forward Guidance
50%
CautiousExpansionary
Neutral (50%)
Forward guidance signal: The fund underperformed its benchmark in Q3 2025 due to zero resource exposure and specific tech/healthcare drags, but the manager capitalized on reporting season volatility to bui...
Language Signal
65%
BearishBullish
Bullish (65%)
Tone analysis indicates above average conviction language: The fund underperformed its benchmark in Q3 2025 due to zero resource exposure and specific tech/healthcare drags, but the manager capitalized on reporting season volatility to bui...
Perceived Risk
40%
Low RiskElevated
Moderate Risk (40%)
Perceived risk level is evaluated as moderate conviction. The fund underperformed its benchmark in Q3 2025 due to zero resource exposure and specific tech/healthcare drags, but the manager capitalized on reporting season volatility to bui...
Opportunity Density
70%
ScarceAbundant
Abundant (70%)
Opportunity density index indicates above average conviction actionable entry points. The fund underperformed its benchmark in Q3 2025 due to zero resource exposure and specific tech/healthcare drags, but the manager capitalized on reporting season volatility to bui...
Time Horizon
90%
Short-TermLong-Term
Decade+ (90%)
Investment time horizon reflects a high conviction orientation. The fund underperformed its benchmark in Q3 2025 due to zero resource exposure and specific tech/healthcare drags, but the manager capitalized on reporting season volatility to bui...